GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoor Harvest Corp (OTCPK:INQD) » Definitions » Risk Assessment

Indoor Harvest (Indoor Harvest) Risk Assessment


View and export this data going back to 2015. Start your Free Trial

What is Indoor Harvest Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Indoor Harvest is: No Data: Cannot be evaluated.

Competitive Comparison of Indoor Harvest's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Indoor Harvest's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indoor Harvest's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indoor Harvest's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Indoor Harvest's Risk Assessment falls into.


Indoor Harvest  (OTCPK:INQD) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Indoor Harvest Risk Assessment Related Terms

Thank you for viewing the detailed overview of Indoor Harvest's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Indoor Harvest (Indoor Harvest) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoor Harvest Corp (OTCPK:INQD) » Definitions » Risk Assessment
Comparable Companies
UPC EVOK AVRW OWPC PRFX AGRX JUVAF CLVR STEK KOAN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
7401 W. Slaughter Lane, Suite 5078, Austin, TX, USA, 78739
Website
https://www.indoorharvest.com
Indoor Harvest Corp develops, process, and provide cannabis medicines. The company provides cannabis industry production platforms for building integrated agriculture (BIA) production. It focuses on Genetics, Tissue Culture, Controlled Environment Ag technologies, including high-pressure Aeroponic Cultivation, Micropropagation, and Cultivation operations. It focuses on an integrated consolidation platform offering for cannabis industry companies focused on hemp, other hemp-related products, CBD, CPG, and ancillary business verticals.
Executives
Daniel Patrick Weadock director, officer: Chief Executive Officer C/O INDOOR HARVEST CORP, 5300 EAST FREEWAY, SUITE A, HOUSTON TX 77020
Benjamin Godoy Coleman 10 percent owner 8518 PEGASUS DR, SELMA TX 78154
Lang Coleman director 8518 PEGASUS DR, SELMA TX 78154
Sandra Fowler officer: Chief Marketing Officer C/O INDOOR HARVEST CORP., 5300 EAST FREEWAY, SUITE A, HOUSTON TX 77020
Sykes Chad Colin director, 10 percent owner, officer: CEO 14830 FOREST LODGE DR., HOUSTON TX 77070
Pawel Hardej director 6304 INDIAN CANYON DR., AUSTIN TX 78746
William Jamieson director PO BOX 47700, PHOENIX AZ 85068
John Alexander Zimmerman director 10258 TIMBER TRAIL DR., DALLAS TX 75229
John Choo director, officer: President 4 NANAIMO DR., OTTAWA A6 K2H 6X5
Annette Lee Knebel director, officer: Chief Accounting Officer C/O INDOOR HARVEST CORP., 5300 EAST FREEWAY, SUITE A, HOUSTON TX 77020
Richard A. Gutshall director, officer: Interim CEO and CFO 7716 ORISHA DRIVE, AUSTIN TX 78739
John Irving Seckman director P.O BOX 3009, IDAHO SPRINGS CO 80452